A Traveler with Fever and a Negative Malaria Smear
A 29-year-old woman returns from 3 weeks in sub-Saharan Africa. She presents with 5 days of fever to 39.5 °C, headache, myalgia, and one episode of vomiting. She took mefloquine prophylaxis but admits missing doses. Vital signs: temperature 39.1 °C, blood pressure 102/64 mmHg, heart rate 112/min. She is alert but tired. The emergency department orders a malaria smear; the laboratory reports no parasites seen on a thick film examined for 10 minutes. Rapid diagnostic test (RDT) for malaria antigen is negative. The team is considering discharging her with symptomatic care. The laboratory is asked whether the negative results are sufficient to exclude malaria.
1. Evaluate the negative smear and RDT and state whether malaria can be excluded.
Read the worked answer
Malaria cannot be excluded on the basis of one negative thick film and a negative RDT. A single thick film examined for 10 minutes has limited sensitivity, especially at low parasitemia, in early infection, or with partial prophylaxis; serial smears every 12–24 hours for up to 72 hours are recommended when the first is negative but suspicion remains. The RDT can be negative in low-parasitemia infection, with certain species (e.g., P. ovale, P. malariae, and some P. falciparum strains with deleted HRP2), and if the test targets an antigen not expressed by the infecting species. Prophylaxis may suppress parasitemia below detection. The combination of a negative smear and negative RDT lowers but does not eliminate the probability of malaria.
2. What additional laboratory and clinical steps should be taken before discharge?
Read the worked answer
Obtain serial thick and thin films every 12–24 hours for up to 72 hours, and consider a species-specific or more sensitive molecular test (PCR) if available. Repeat the RDT with a different antigen target if the first was HRP2-based, and send a complete blood count, chemistry, and blood cultures to evaluate for alternative diagnoses. Assess for other travel-associated infections (dengue, typhoid, rickettsial disease) based on exposure and exposures. Clinically, the patient has tachycardia and borderline blood pressure; she should not be discharged without a clear plan for repeat testing and instructions to return for worsening symptoms. If she is discharged, she needs reliable follow-up and explicit return precautions.
3. If a repeat thick film shows ring-form trophozoites, how should the laboratory proceed and what should be communicated?
Read the worked answer
The laboratory should identify the species if possible (thin film, morphology, and parasitemia quantification as a percentage of red cells), report the parasitemia level, and notify the clinician urgently. Species matters because P. falciparum can progress rapidly and may require intravenous artesunate for severe disease, while P. vivax and P. ovale require a hypnozoite-eradicating agent (primaquine or tafenoquine) after G6PD testing. The report should include the parasite density because high parasitemia is a severity marker. The laboratory should also flag that the earlier negative results do not change the need for treatment now, and should coordinate with the clinician on whether the patient meets criteria for severe malaria (e.g., impaired consciousness, hypotension, acidosis, high parasitemia).